Gardner Lewis Asset Management’s CORNERSTONE THERAPEUTICS INC CRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q1
Sell
-379,034
Closed -$3.6M 100
2013
Q4
$3.6M Buy
379,034
+98,134
+35% +$929K 1.21% 36
2013
Q3
$2.64M Buy
+280,900
New +$2.53M 0.72% 60

Other funds holding CRTX

Gardner Lewis Asset Management's CRTX Position: Q1 2014 in Review

Gardner Lewis Asset Management sold out of CORNERSTONE THERAPEUTICS INC (CRTX) in Q1 2014, closing a stake of 379,034 shares — an estimated $3.6M sold.

Gardner Lewis Asset Management first reported a position in CRTX in Q3 2013 and held it in 2 quarters. The position peaked at $3.6M in Q4 2013. 1 fund tracked by Wall St. Rank holds CRTX as of Q1 2014.

  • Gardner Lewis Asset Management reported no remaining CORNERSTONE THERAPEUTICS INC position as of Q1 2014 after selling out during the quarter.
  • Gardner Lewis Asset Management sold 379,034 CORNERSTONE THERAPEUTICS INC shares in Q1 2014, an estimated $3.6M.
  • Gardner Lewis Asset Management first reported a position in CORNERSTONE THERAPEUTICS INC in Q3 2013 and held it in 2 quarters.
  • Gardner Lewis Asset Management's CORNERSTONE THERAPEUTICS INC position peaked at $3.6M in Q4 2013.
  • 1 fund tracked by Wall St. Rank held CORNERSTONE THERAPEUTICS INC as of Q1 2014.

Based on Gardner Lewis Asset Management's 13F filing for Q1 2014, filed 14 May 2014.